Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Scott Buckner

Vascular & Interventional Radiology Eldersburg, MD Medical Doctor

NPI 1003887969 CMS profile 181823

1330 Liberty Rd, Suite H, Eldersburg, MD 21784

Open in the dashboard

General payments

$16,983

64 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Scott Buckner of Eldersburg, MD is reported in the CMS Open Payments database as having received $16,983 across 64 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $289 11
2024 General $1,684 9
2023 General $1,798 8
2022 General $2,133 13
2021 General $1,381 15
2020 General $4,839 3
2019 General $4,859 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Buckner
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Scott Buckner were reported at $289. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Scott Buckner Vascular & Interventional Radiology median Middle half National median
2019 $4,859 $422 $125–$1,555 $163
2020 $4,839 $200 $68–$652 $114
2021 $1,381 $280 $99–$866 $132
2022 $2,133 $433 $137–$1,497 $149
2023 $1,798 $506 $152–$2,019 $160
2024 $1,684 $556 $175–$1,930 $164
2025 $289 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $9,600 2 payments
  2. Philips Electronics North America Corporation $4,930 19 payments
  3. Bard Peripheral Vascular, Inc. $1,828 19 payments
  4. Boston Scientific Corporation $275 9 payments
  5. Revance Therapeutics, Inc. $89 4 payments
  6. Cardiovascular Systems Inc. $88 1 payment
  7. Tactile Systems Technology Inc $70 4 payments
  8. ConvaTec Inc. $21 1 payment
  9. AbbVie, Inc. $19 1 payment
  10. Galderma Laboratories, L.P. $19 1 payment
  11. Other $44 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $9,600 2 payments
  2. Consulting Fee $4,200 3 payments
  3. Food and Beverage $3,107 58 payments
  4. Entertainment $76 1 payment
Products named General payments · program years 2019–2025
  1. EVLT $9,600 2 payments
  2. (9520) IGT Devices Undivided $4,200 3 payments
  3. Venclose Maven Catheter Vascular/Oncology $282 4 payments
  4. Varithena Administration Pack $255 8 payments
  5. (9547) IGT Systems Und $243 5 payments
  6. Venclose Maven Catheter BD Interventional Peripheral Intervention $160 2 payments
  7. (CQ0) Azurion 5 M20 GC $115 2 payments
  8. (7882) Image Guided Therapy Und $107 2 payments
  9. (5028) IGT Devices Systems Undivided $94 1 payment
  10. DAXXIFY $89 4 payments
  11. Other $426 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$288,861

Medicare's payments for the services billed

Medicare patients

121

Average age 73

Services billed

761

87 women, 34 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 64%
Arthritis 51%
Ischemic heart disease 22%
Osteoporosis 21%
Diabetes 18%
Atrial fibrillation 17%
COPD 13%
Cancer 12%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DAXXIFY
  • REVANCE THERAPEUTICS, INC. $66
$66 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

64 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record